Manasi Agrawal
Overview
Explore the profile of Manasi Agrawal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahoo P, Agrawal M, Hanovice N, Ward P, Desai M, Smith T, et al.
Proc Natl Acad Sci U S A
. 2025 Feb;
122(9):e2411811122.
PMID: 40014573
Depletion or inhibition of core stress granule proteins, G3BP1 in mammals and TIAR-2 in , increases the growth of spontaneously regenerating axons. Inhibition of G3BP1 by expression of its acidic...
2.
Desai M, Gulati K, Agrawal M, Ghumra S, Sahoo P
Neural Regen Res
. 2025 Feb;
PMID: 39995077
Stress granules are membraneless organelles that serve as a protective cellular response to external stressors by sequestering non-translating messenger RNAs (mRNAs) and regulating protein synthesis. Stress granules formation mechanism is...
3.
Shenoy S, Jena A, Levinson C, Sharma V, Deepak P, Aswani-Omprakash T, et al.
Lancet Gastroenterol Hepatol
. 2025 Feb;
10(3):259-274.
PMID: 39954693
Inflammatory bowel disease (IBD) is rising at an alarming rate in south Asia and there is a paucity of data on IBD in this region. For this scoping review, we...
4.
Tarassishin L, Kim T, Hu J, Barre A, Rendon A, Picker M, et al.
Dig Dis Sci
. 2025 Jan;
PMID: 39856480
Background: Fecal lipocalin-2 (LCN2) is a biomarker of neutrophil activation, which is elevated in patients with inflammatory bowel disease (IBD); however, its dynamic changes during pregnancy and early life are...
5.
Lacoste J, Ahmed T, Rajauria P, Agrawal M, Wong S, Grinspan L
J Gen Intern Med
. 2025 Jan;
PMID: 39762676
No abstract available.
6.
Peraza J, Kaper M, Bargas A, Kim I, Agrawal M, Larsen L, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):1011-1018.
PMID: 39757503
Background: Up to 30% of patients with Crohn's disease (CD) will experience a mild disease course. However, there is no consensus definition for mild CD. Aim: To examine the Simple...
7.
Jacobsen H, Karachalia-Sandri A, Ebert A, Allin K, Ananthakrishnan A, Agrawal M, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39675406
Background & Aims: The inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD), are heterogenous diseases ranging from mild to severe. We aimed to describe the prevalence and...
8.
Gros B, Peraza J, Bassi M, Sleiman J, Abdelhalim S, Park E, et al.
J Crohns Colitis
. 2024 Dec;
PMID: 39657593
Background And Aims: Female physicians, particularly those from minority populations, are significantly underrepresented in research authorship in gastroenterology. This underrepresentation negatively impacts their career progression. This study analyses gender and...
9.
Singh S, Loftus Jr E, Limketkai B, Haydek J, Agrawal M, Scott F, et al.
Gastroenterology
. 2024 Nov;
167(7):1307-1343.
PMID: 39572132
Background & Aims: This American Gastroenterological Association (AGA) living guideline is intended to support practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC). Methods: A multidisciplinary panel of content...
10.
Agrawal M, Ungaro R, Rajauria P, Magee J, Petrick L, Midya V
Gastroenterology
. 2024 Nov;
168(3):608-611.e4.
PMID: 39549765
No abstract available.